Amneal Pharmaceuticals Inc - Ordinary Shares - Class A

NYSE:AMRX  
4.46
+0.06 (+1.36%)
Mergers / Acquisitions

Amneal Acquires Saol Therapeutics’ Baclofen Franchise

Published: 01/05/2022 18:58 GMT
Amneal Pharmaceuticals Inc - Ordinary Shares - Class A (AMRX) - Amneal Acquires Saol Therapeutics’ Baclofen Franchise.
Amneal Pharmaceuticals Inc - Transaction is Expected to Be Accretive to Amneal's Adjusted EBITDA and Adjusted Earnings per Share Results for 2022.
Amneal Pharmaceuticals Inc - Under Terms of Transaction, Amneal Will Pay About $83.5 Million of Cash at Close.
Amneal Pharmaceuticals Inc - Transaction Will Be Financed With Cash on Hand.